InvestorsHub Logo
Followers 36
Posts 1468
Boards Moderated 0
Alias Born 11/12/2013

Re: olden_grumpini post# 363260

Tuesday, 06/22/2021 11:06:56 AM

Tuesday, June 22, 2021 11:06:56 AM

Post# of 402942
What's your sources or RU just making assertions?

Message in reply to:

It’s flawed logic to assume that brilacidin would be purchased by countries that cannot afford to vaccinate their populations (third world countries). If a country can’t afford $25 to vaccinate they are unlikely to be a viable market for a costly drug like brilacidin with a complicated method of delivery.

As to vaccinations . . . I think it’s a lack of historical knowledge to suggest that the rate of vaccination is slow. Vaccinating 2.4 billion people in 6 months is nothing short of astounding. And don’t forget that the people being vaccinated first are those most susceptible to COVID.

We all know that the antiviral market is huge, but it was also huge when brilacidin was developed by Polymedix. Why wasn’t brilacidin developed as an antiviral by Polymedix?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News